DiappyMed Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$5.81M
- Investors
-
8
DiappyMed General Information
Description
Developer of a digital health platform designed to provide intelligent and personalized insulin dosing. The company's platform calculates insulin dosage based on inputs such as current blood sugar levels, planned meals, and physical activity, enabling individuals to enhance the daily management of diabetes.
Contact Information
Website
www.diappymed.comCorporate Office
- Cap Alpha, 3 Avenue de l'Europe
- 34830 Clapiers
- France
Corporate Office
- Cap Alpha, 3 Avenue de l'Europe
- 34830 Clapiers
- France
DiappyMed Timeline
DiappyMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 23-Mar-2026 | $5.81M | Completed | Generating Revenue | ||
| 5. Seed Round | 27-Jul-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Sep-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Mar-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Feb-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue |
DiappyMed Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DiappyMed Patents
DiappyMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3129071-A1 | Device for dynamic basal insulin dose determination to be injected | Active | 18-Nov-2021 | ||
| CA-3230470-A1 | Device for dynamic determination of a basal insulin dose to be injected | Pending | 18-Nov-2021 | ||
| EP-4392980-A1 | Device for dynamic determination of a basal insulin dose to be injected | Pending | 18-Nov-2021 | ||
| US-20260157662-A1 | Device for dynamic determination of a basal insulin dose to be injected | Pending | 18-Nov-2021 | ||
| WO-2023089121-A1 | Device for dynamic determination of a basal insulin dose to be injected | Inactive | 18-Nov-2021 | A61B5/14532 |
DiappyMed Signals
DiappyMed Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AFI Ventures | Venture Capital | Minority | ||
| Ventech (Paris) | Venture Capital | Minority | ||
| IRDI Capital Investissement | PE/Buyout | Minority | ||
| Sofilaro | PE/Buyout | Minority | ||
| Future4care | Accelerator/Incubator |
DiappyMed FAQs
-
When was DiappyMed founded?
DiappyMed was founded in 2021.
-
Where is DiappyMed headquartered?
DiappyMed is headquartered in Clapiers, France.
-
What is the size of DiappyMed?
DiappyMed has 16 total employees.
-
What industry is DiappyMed in?
DiappyMed’s primary industry is Other Healthcare Technology Systems.
-
Is DiappyMed a private or public company?
DiappyMed is a Private company.
-
What is DiappyMed’s current revenue?
The current revenue for DiappyMed is .
-
How much funding has DiappyMed raised over time?
DiappyMed has raised $6.19M.
-
Who are DiappyMed’s investors?
AFI Ventures, Ventech (Paris), IRDI Capital Investissement, Sofilaro, and Future4care are 5 of 8 investors who have invested in DiappyMed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process